- Home
- LSB vs CB Comparison
LSB vs CB Comparison
Compare LSB & CB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- CB
- Stock Information
- Founded
- LSB 2002
- CB 1985
- Country
- LSB China
- CB Switzerland
- Employees
- LSB 758
- CB N/A
- Industry
- LSB
- CB Property-Casualty Insurers
- Sector
- LSB
- CB Finance
- Exchange
- LSB NYSE
- CB Nasdaq
- Market Cap
- LSB 72.7M
- CB N/A
- IPO Year
- LSB N/A
- CB 1993
- Fundamental
- Price
- LSB $3.86
- CB $284.38
- Analyst Decision
- LSB
- CB Buy
- Analyst Count
- LSB 0
- CB 20
- Target Price
- LSB N/A
- CB $284.00
- AVG Volume (30 Days)
- LSB 130.1K
- CB 1.7M
- Earning Date
- LSB 10-18-2024
- CB 10-29-2024
- Dividend Yield
- LSB N/A
- CB 1.28%
- EPS Growth
- LSB N/A
- CB 70.98
- EPS
- LSB N/A
- CB 23.67
- Revenue
- LSB $79,415,311.00
- CB $53,619,000,000.00
- Revenue This Year
- LSB $39.33
- CB N/A
- Revenue Next Year
- LSB $75.61
- CB $6.53
- P/E Ratio
- LSB N/A
- CB $12.02
- Revenue Growth
- LSB N/A
- CB 15.29
- 52 Week Low
- LSB $3.20
- CB $205.64
- 52 Week High
- LSB $11.20
- CB $294.18
- Technical
- Relative Strength Index (RSI)
- LSB 33.86
- CB 46.03
- Support Level
- LSB $3.20
- CB $275.22
- Resistance Level
- LSB $8.60
- CB $293.71
- Average True Range (ATR)
- LSB 0.78
- CB 4.89
- MACD
- LSB -0.52
- CB -1.76
- Stochastic Oscillator
- LSB 11.67
- CB 41.37
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.